Alderman is reporting to Varsha Rao, Clover’s COO
The pharma giant will take up 15 floors of a new Manhattan skyscraper.
Clayman says the company’s next 18 months are all about Zilretta, with further pipeline construction next up.
A plea for IT interoperability and a stinging criticism of the pharma industry over its lack of diversity were two highlights of yesterday’s events.
Maker of Botox biosimilar Evolus files IPO; pharma execs expect major acquisitions in 2018; J&J and Bayer win Xarelto reversal verdict
How drugmakers should prepare for and respond to the forces poised to reshape the industry was a popular topic on day one of the 36th annual JP Morgan Healthcare Conference.
Shire considers splitting into two units; New Jersey finalizes physician-pharma gift limit; more biotech M&As expected in 2018
Allergan to cut 1,000 jobs; McKesson acquires RxCrossroads from CVS Health; Pfizer and Sangamo enter collaboration to develop ALS gene therapy
VP of investor relations Teri Loxam will take over Ambrose’s role in January.
Pharma R&D return on investment falls to eight-year low; FDA approves Pfizer’s biosimilar to J&J’s Remicade; Novartis to downsize generics business
Get to know each of these companies by learning about their culture, work/life balance, D&I initiatives and more.
OptimizeRx’s Chris DiCostanzo and Rebecca Love explain the value of reaching patients and HCPs when it matters most.
Talking Medicines’ Jo Halliday discussed how the pharmaceutical sector can better understand the voice of the patient.
Learn about Intouch Group’s journey to foster I+D so that its inclusive culture translates into inclusive healthcare marketing.
Any EHR provider delivering a quality solution should be able to answer these six questions.
Please login or register first to view this content.